{"id":174,"date":"2025-07-02T16:13:22","date_gmt":"2025-07-02T16:13:22","guid":{"rendered":"https:\/\/proximitywedev.wpenginepowered.com\/?page_id=174"},"modified":"2026-01-28T18:03:42","modified_gmt":"2026-01-28T18:03:42","slug":"news","status":"publish","type":"page","link":"https:\/\/proximity2edc.com\/?page_id=174","title":{"rendered":"Customers"},"content":{"rendered":"<p><main id=\"PAGES_CONTAINER\" class=\"PAGES_CONTAINER\" data-main-content=\"true\" tabindex=\"-1\"><\/main><\/p>\n<div id=\"SITE_PAGES\" class=\"JsJXaX SITE_PAGES\">\n<div id=\"SITE_PAGES_TRANSITION_GROUP\" class=\"AnQkDU\">\n<div id=\"c6w96\" class=\"dBAkHi c6w96\">\n<div class=\"HT5ybB\">\n<div id=\"Containerc6w96\" class=\"Containerc6w96 SPY_vo\">\n<div data-mesh-id=\"Containerc6w96inlineContent\" data-testid=\"inline-content\" class=\"\">\n<div data-mesh-id=\"Containerc6w96inlineContent-gridContainer\" data-testid=\"mesh-container-content\">\n<section id=\"comp-lon9iejj\" class=\"Oqnisf comp-lon9iejj wixui-section\" data-block-level-container=\"ClassicSection\" aria-label=\"main content\" tabindex=\"-1\">\n<div data-mesh-id=\"comp-lon9iejjinlineContent\" data-testid=\"inline-content\" class=\"\">\n<div data-mesh-id=\"comp-lon9iejjinlineContent-gridContainer\" data-testid=\"mesh-container-content\">\n<section id=\"comp-l3t9q0lx\" class=\"comp-l3t9q0lx CohWsy wixui-column-strip\">\n<div data-testid=\"columns\" class=\"V5AUxf\">\n<div id=\"comp-l3t9q0m1\" class=\"comp-l3t9q0m1 YzqVVZ wixui-column-strip__column\">\n<div data-mesh-id=\"comp-l3t9q0m1inlineContent\" data-testid=\"inline-content\" class=\"\">\n<div data-mesh-id=\"comp-l3t9q0m1inlineContent-gridContainer\" data-testid=\"mesh-container-content\">\n<div id=\"comp-l3t9q0mb\" class=\" comp-l3t9q0mb wixui-repeater\">\n<div role=\"list\" class=\"hRdzm4\">\n<div class=\"cGWabE\">\n<div role=\"listitem\" class=\"T7n0L6\">\n<div id=\"comp-l3t9q0mn__111cc671-92ce-4b4f-b806-4c046aab4bde\" class=\"comp-l3t9q0mn YzqVVZ wixui-repeater__item\">\n<div data-mesh-id=\"comp-l3t9q0mn__111cc671-92ce-4b4f-b806-4c046aab4bdeinlineContent\" data-testid=\"inline-content\" class=\"\">\n<div data-mesh-id=\"comp-l3t9q0mn__111cc671-92ce-4b4f-b806-4c046aab4bdeinlineContent-gridContainer\" data-testid=\"mesh-container-content\">\n<div id=\"comp-l3t9q0nb__111cc671-92ce-4b4f-b806-4c046aab4bde\" class=\"Z_l5lU MMl86N zQ9jDz qvSjx3 Vq6kJx comp-l3t9q0nb wixui-rich-text\" data-testid=\"richTextElement\">\n<div>Following the 2022 launch of proXimity, we have focused on advancing and optimizing our platform, and we are now ready to transition into full commercial rollout.<\/div>\n<div><\/div>\n<div>During the initial launch stage, proXimity experienced rapid adoption by researchers and clinicians. At this time, proXimity is:<\/div>\n<ul>\n<li>\n<div role=\"presentation\">working with <b>15 CROs, including<\/b>\u00a0<b>80% of the Top 10 CROs<\/b><\/div>\n<\/li>\n<li>\n<div role=\"presentation\">the data transfer tool at<b>\u00a0over 250 trial sites<\/b><\/div>\n<\/li>\n<li><span>automating data transfer for over 160 active trials, with over 650,000 data elements transferred to date<\/span><\/li>\n<\/ul>\n<div><\/div>\n<div>A <a title=\"https:\/\/proximity2edc.com\/?page_id=4411\" id=\"m_-5349520707986810116OWA811c347d-9958-e751-2340-536f69f7a669\" href=\"https:\/\/proximity2edc.com\/?page_id=4411\" target=\"_blank\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/proximity2edc.com\/?page_id%3D4411&amp;source=gmail&amp;ust=1764882592934000&amp;usg=AOvVaw1beLR6waVgULlZZXWJjGm8\" rel=\"noopener\">whitepaper<\/a>, co-authored by representatives from NEXT Oncology, Precision for Medicine, and Equicare Health has been published, as a case study, and call to action, for the advance of technical solutions to support automated data transfer in clinical trials.<\/div>\n<div><\/div>\n<div>Read more about early proXimity adopters in our <span><a href=\"https:\/\/proximity2edc.com\/?page_id=4635\" target=\"_blank\" rel=\"noopener\">customer news archive<\/a>.<\/span><\/div>\n<\/div>\n<p>&nbsp;<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n<\/div>\n<\/div>\n<\/section>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Following the 2022 launch of proXimity, we have focused on advancing and optimizing our platform, and we are now ready to transition into full commercial rollout. During the initial launch stage, proXimity experienced rapid adoption by researchers and clinicians. At this time, proXimity is: working with 15 CROs, including\u00a080% of [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page-templates\/template-fullwidth.php","meta":{"_themeisle_gutenberg_block_has_review":false,"footnotes":""},"class_list":["post-174","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/proximity2edc.com\/index.php?rest_route=\/wp\/v2\/pages\/174","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/proximity2edc.com\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/proximity2edc.com\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/proximity2edc.com\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/proximity2edc.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=174"}],"version-history":[{"count":0,"href":"https:\/\/proximity2edc.com\/index.php?rest_route=\/wp\/v2\/pages\/174\/revisions"}],"wp:attachment":[{"href":"https:\/\/proximity2edc.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=174"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}